Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer

Clinical trial NCT00623064 · COMPLETED

Trial details

NCT number: NCT00623064
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Cancer Transitional Cell Cancer of the Renal Pelvis and Ureter

Start date: 2007-11-01
Primary completion: 2012-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.